Rhythm Pharmaceuticals (RYTM) Inventory (2021 - 2026)

Rhythm Pharmaceuticals (RYTM) has 6 years of Inventory data on file, last reported at $28.7 million in Q1 2026.

• Inventory for Q1 2026 came in at $28.7 million, up 48.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.7 million (up 48.33% YoY), and the FY2025 annual result was $25.8 million, up 37.42% from the prior year.
• Inventory advanced to $28.7 million in Q1 2026 per RYTM's latest filing, from $25.8 million in the prior quarter.
• Over five years, Inventory peaked at $28.7 million in Q1 2026 and troughed at $2.9 million in Q4 2022.
• A 5-year average of $14.2 million and a median of $12.9 million in 2024 frame the typical range for Inventory.
• The sharpest annual moves came in 2022 and 2025: Inventory jumped 2527.93% in 2022, then surged 37.42% in 2025.
• A 5-year view of Inventory shows it stood at $2.9 million in 2022, then soared by 195.65% to $8.6 million in 2023, then surged by 117.31% to $18.7 million in 2024, then soared by 37.42% to $25.8 million in 2025, then gained by 11.25% to $28.7 million in 2026.
• Business Quant data shows RYTM's Inventory at $28.7 million in Q1 2026, $25.8 million in Q4 2025, and $22.1 million in Q3 2025.